Standard InChI: InChI=1S/C26H31NO7/c1-27-14-18(8-16-10-20(29-2)25(33-6)21(11-16)30-3)24(28)19(15-27)9-17-12-22(31-4)26(34-7)23(13-17)32-5/h8-13H,14-15H2,1-7H3/b18-8+,19-9+
1.Yadav B, Taurin S, Rosengren RJ, Schumacher M, Diederich M, Somers-Edgar TJ, Larsen L.. (2010) Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin., 18 (18):[PMID:20728364][10.1016/j.bmc.2010.07.063]
2.Deck LM, Hunsaker LA, Vander Jagt TA, Whalen LJ, Royer RE, Vander Jagt DL.. (2018) Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin., 143 [PMID:29223100][10.1016/j.ejmech.2017.11.048]
3.Chen L, Li Q, Weng B, Wang J, Zhou Y, Cheng D, Sirirak T, Qiu P, Wu J.. (2018) Design, synthesis, anti-lung cancer activity, and chemosensitization of tumor-selective MCACs based on ROS-mediated JNK pathway activation and NF-κB pathway inhibition., 151 [PMID:29655083][10.1016/j.ejmech.2018.03.051]
4.Zhang Y, Liu Z, Wu J, Bai B, Chen H, Xiao Z, Chen L, Zhao Y, Lum H, Wang Y, Zhang H, Liang G.. (2018) New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity., 148 [PMID:29466778][10.1016/j.ejmech.2018.02.008]
5.Moreira J, Saraiva L, Pinto MM, Cidade H.. (2020) Diarylpentanoids with antitumor activity: A critical review of structure-activity relationship studies., 192 [PMID:32172081][10.1016/j.ejmech.2020.112177]